Brian Cogley
Vermögen: 418 950 $ am 31.05.2026
Vermögen: 418 950 $ am 31.05.2026
Brian Cogley is currently Chief Financial Officer at Coeptis Therapeutics, Inc. since 2023 and Chief Financial Officer at Z Squared, Inc. starting in 2026.
Former positions include Senior Manager-Accounting Advisory at Cfgi LLC, Vice President-Finance & Accounting at NexTier Bank, NA from 2017 to 2022, and Chief Financial Officer at Coeptis Therapeutics Holdings, Inc. Education includes undergraduate and MBA degrees from Duquesne University of The Holy Spirit.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
0.09% | 27.04.2026 | 45’000 ( 0.09% ) | 418 950 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| NAERODYNAMICS INC | Finanzdirektor/CFO | 17.05.2023 |
| Unternehmen | Position | Ende |
|---|---|---|
NexTier Bank, NA
NexTier Bank, NA Major BanksFinance Provides national banking solutions | Finanzdirektor/CFO | 01.02.2022 |
| COEPTIS THERAPEUTICS | Finanzdirektor/CFO | - |
Cfgi LLC /Privategroup/
Cfgi LLC /Privategroup/ Financial ConglomeratesFinance Acts as a private group led by CVC Advisors (US) Inc and management and existing investor of CFGI LLC | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Coeptis Therapeutics, Inc.
Coeptis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and supplies novel therapy products for cancer patients | Health Technology |
Duquesne University of The Holy Spirit
Duquesne University of The Holy Spirit Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NexTier Bank, NA
NexTier Bank, NA Major BanksFinance Provides national banking solutions | Finance |
Cfgi LLC /Privategroup/
Cfgi LLC /Privategroup/ Financial ConglomeratesFinance Acts as a private group led by CVC Advisors (US) Inc and management and existing investor of CFGI LLC | Finance |
Coeptis Therapeutics Holdings, Inc.
Coeptis Therapeutics Holdings, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company developing innovative cell therapy platforms for patients with cancer | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen